Amir A Jazaeri1, Jill K Slack-Davis. Show Affiliations » 1. W. Norman Thornton Division of Gynecologic Oncology, University of Virginia, Charlottesville, VA, USA. aj2a@virginia.edu
Abstract
Entities: Disease
Mesh： See more » Angiogenesis Inhibitors/therapeutic useAnimalsFemaleHumansIntegrin alphaVbeta3/antagonists & inhibitorsIntegrin alphaVbeta3/geneticsIntegrin alphaVbeta3/metabolismOvarian Neoplasms/drug therapyOvarian Neoplasms/metabolismVascular Endothelial Growth Factor A/antagonists & inhibitorsVascular Endothelial Growth Factor A/geneticsVascular Endothelial Growth Factor A/metabolism
Substances： See more » Angiogenesis InhibitorsIntegrin alphaVbeta3Vascular Endothelial Growth Factor Avascular endothelial growth factor A, mouse
Year: 2009 PMID： 19907207 DOI： 10.4161/cbt.8.23.10414
Source DB: PubMed Journal: Cancer Biol Ther ISSN： 1538-4047 Impact factor: 4.742